Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nicotine
100%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Muscle Type
100%
Cell Signaling Pathways
100%
Non-small Cell Lung Cancer Cells
100%
Non-small Cell Lung Cancer (NSCLC)
36%
Lung Tumor
27%
Mitogen-activated Protein Kinase
27%
Neuronal Subtypes
27%
Protein Expression
18%
Gefitinib
18%
Hexamethonium
18%
Human Lung Cancer Cell Line
18%
P44/42 Mitogen-activated Protein Kinase
18%
Lung
9%
Tobacco Products
9%
MRNA Expression
9%
Immunohistochemistry
9%
Cancer Development
9%
Phosphorylation
9%
Expression Level
9%
Therapeutic Efficacy
9%
Non-small Cell Lung Cancer Patients
9%
Nicotine Exposure
9%
Primary Tissue
9%
PI3K Inhibitor
9%
High-level Expression
9%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
9%
Neuronal Cells
9%
Cell-free Extract
9%
Immunoblot
9%
α-bungarotoxin
9%
L-type Calcium Channel
9%
Akt Activation
9%
Receptor 1
9%
LY294002
9%
Non-neuronal Cells
9%
Chronic Nicotine
9%
Bronchial Tissue
9%
Nicotine Replacement Products
9%
Surviving Cells
9%
Airway Cells
9%
Non-neuronal Acetylcholine
9%
Normal Bronchial Epithelial Cells
9%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
9%
Non-tumor
9%
Medicine and Dentistry
Cancer Cell
100%
Cell Signaling Pathway
100%
Non Small Cell Lung Cancer
100%
Nicotinic Receptor
100%
Nicotine
100%
Receptor
33%
Lung Tumor
25%
Mitogen-Activated Protein Kinase
25%
Protein Kinase B
25%
Messenger RNA
25%
Protein Expression
16%
Hexamethonium
16%
Lung Cancer Cell Line
16%
Gefitinib
16%
Isotopes of Calcium
8%
Lung
8%
Epithelial Cell
8%
Acetylcholine
8%
Immunohistochemistry
8%
Mitogen Activated Protein Kinase 3
8%
Cell Extract
8%
L-Type Calcium Channel
8%
Tyrosine-Kinase Inhibitor
8%
Epidermal Growth Factor Receptor
8%
Non-Neuronal Cell
8%
LY294002
8%
EGFR Inhibitors
8%
Airway Cell
8%
Receptor Subunit
8%
Bronchus Tumor
8%
Nicotinic Acetylcholine Receptor Antagonist
8%
Cell Line
8%
Immunoblotting
8%
Bungarotoxin
8%
phosphorylation
8%
Neuroscience
Cell Signaling
100%
Nicotinic Acetylcholine Receptor
100%
Nicotine
100%
Receptor
36%
Mitogen-Activated Protein Kinase
27%
Protein Kinase B
27%
Cell Line
27%
Messenger RNA
27%
Hexamethonium
18%
Gefitinib
18%
Protein Expression
18%
Epidermal Growth Factor Receptor
18%
Epithelial Cells
9%
LY294002
9%
Acetylcholine
9%
Receptor Antagonist
9%
Mitogen Activated Protein Kinase 3
9%
Receptor Subunit
9%
L-Type Calcium Channel
9%
Tyrosine Kinase Inhibitor
9%
Immunohistochemistry
9%
Bungarotoxin
9%
Immunoblotting
9%
phosphorylation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Nicotinic Receptor
100%
Nicotine
100%
Receptor
33%
Lung Tumor
25%
Mitogen Activated Protein Kinase
25%
Protein Kinase B
25%
Messenger RNA
25%
Gefitinib
16%
Hexamethonium
16%
Epidermal Growth Factor Receptor
16%
Western Blot
8%
Nicotinic Acetylcholine Receptor Antagonist
8%
Bungarotoxin
8%
Protein Tyrosine Kinase Inhibitor
8%
Mitogen Activated Protein Kinase 3
8%
Cell Extract
8%
2 Morpholino 8 Phenylchromone
8%
Receptor Subunit
8%
Calcium Channel L Type
8%
Bronchus Tumor
8%
Acetylcholine
8%